ClinicalTrials.Veeva
Menu

Find clinical trials for Prostate Cancer in Dallas, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Prostatic Cancer
Cancer
Carcinoma
Hypersensitivity
Adenocarcinoma
Recurrence
Castration-Resistant Prostatic Cancer

Prostate Cancer trials near Dallas, TX, USA:

Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)

pharmacodynamic (PD), and the preliminary efficacy of JANX007 administered as a single agent in adults with metastatic castration-resistant prostate...

Enrolling
Castration Resistant Prostatic Cancer
Metastatic Castration-resistant Prostate Cancer
Biological: JANX007

Phase 1

Janux Therapeutics

Dallas, Texas, United States and 10 other locations

single-arm, two-stage open-label phase 2 study of the combination of cabozantinib + nivolumab in subjects with advanced castration-resistant prostate...

Enrolling
Metastatic Cancer
Castration-resistant Prostate Cancer
Drug: Cabozantinib
Drug: Nivolumab

Phase 2

Rana McKay, MD

Dallas, Texas, United States and 2 other locations

Recently updated

radiation therapy for patients with intermediate-high risk localized prostate cancer. ProstAtak kills tumor cells and stimulates a ...

Active, not recruiting
Prostate Cancer
Biological: Placebo + valacyclovir
Biological: Aglatimagene besadenovec + valacyclovir

Phase 3

Candel Therapeutics

Dallas, Texas, United States and 72 other locations

recommended Phase 2 dose (RP2D) and/or maximum tolerated dose (MTD) and preliminary antitumor activity of ORIC-944 in patients with metastatic prostate...

Enrolling
Neuroendocrine Prostate Cancer
Metastatic Prostate Cancer
Drug: ORIC-944

Phase 1

Oric Pharmaceuticals

Dallas, Texas, United States and 5 other locations

Confirming safety of combining UroLift System prior to SAbR for patients with newly diagnosed prostate cancer and a history of BPH,...

Enrolling
Prostate Cancer
Device: Urolift
Radiation: SABR

Phase 1

The University of Texas System (UT)
The University of Texas System (UT)

Dallas, Texas, United States

The purpose of this study is to collect long term safety data in subjects who are continuing to derive clinical benefit from treatment with Enzalutam...

Enrolling
Prostate Cancer
Drug: prednisone
Drug: enzalutamide

Phase 2

Astellas
Astellas

Dallas, Texas, United States and 225 other locations

period and an additional 40-week safety extension period in men with prostate cancer, either metastatic castration-sensitive prostate...

Active, not recruiting
Metastatic Castration-Resistant Prostate Cancer
Non-Metastatic Castration-Resistant Prostate Cancer
Drug: Abiraterone
Drug: Methylprednisolone

Phase 1

Sumitomo Pharma
Sumitomo Pharma

Dallas, Texas, United States and 15 other locations

Recently updated

The purpose of this study is to evaluate the efficacy and safety of apalutamide in adult men with high-risk non-metastatic castration-resistant prostate...

Active, not recruiting
Prostatic Neoplasms
Drug: Apalutamide
Drug: Placebo

Phase 3

Aragon Pharmaceuticals

Dallas, Texas, United States and 388 other locations

plus docetaxel in participants with metastatic castration resistant prostate cancer (mCRPC), all participants will receive the doce...

Enrolling
Prostate Cancer
Drug: docetaxel
Drug: capivasertib

Phase 3

AstraZeneca
AstraZeneca

Dallas, Texas, United States and 249 other locations

in participants with high-risk, localized or locally advanced prostate cancer receiving primary radiation therapy (RT) results in a...

Active, not recruiting
Prostatic Neoplasms
Drug: Bicalutamide Placebo
Radiation: 74-80 Grays (units of radiation)

Phase 3

Aragon Pharmaceuticals

Dallas, Texas, United States and 271 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems